Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Benefit of population-based screening for phenotypic hemochromatosis in young men.

Asberg A, Tretli S, Hveem K, Bjerve KS.

Scand J Gastroenterol. 2002 Oct;37(10):1212-9.

PMID:
12408528
2.
3.

[Genetic hemochromatosis: importance of population screening?].

Cartabellotta A, Montalto G.

Recenti Prog Med. 1996 Mar;87(3):118-23. Review. Italian.

PMID:
8650432
4.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
6.
7.

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.

Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JA, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M; Chlamydia Screening Studies Project Group.

Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165. Review.

8.

Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.

Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N.

Health Technol Assess. 2004 May;8(20):iii, 1-78. Review.

9.

[Should we screen for hemochromatosis? Critical analysis of the literature].

Charvet-Protat S, Yaouanq J, Fleurette F.

Rev Epidemiol Sante Publique. 1997 Sep;45(4):315-27. Review. French.

PMID:
9380912
10.

Screening for hemochromatosis: phenotype versus genotype.

Edwards CQ, Griffen LM, Ajioka RS, Kushner JP.

Semin Hematol. 1998 Jan;35(1):72-6. Review.

PMID:
9460810
11.

Cost utility analysis of radiographic screening for an orbital foreign body before MR imaging.

Seidenwurm DJ, McDonnell CH 3rd, Raghavan N, Breslau J.

AJNR Am J Neuroradiol. 2000 Feb;21(2):426-33. Review.

12.

Screening for hemochromatosis. A public health perspective.

Cogswell ME, Burke W, McDonnell SM, Franks AL.

Am J Prev Med. 1999 Feb;16(2):134-40. Review.

PMID:
10343890
13.

Arthropathy in hereditary hemochromatosis.

von Kempis J.

Curr Opin Rheumatol. 2001 Jan;13(1):80-3. Review.

PMID:
11148720
14.

Strategies for early diagnosis of haemochromatosis.

Niederau C, Strohmeyer G.

Eur J Gastroenterol Hepatol. 2002 Mar;14(3):217-21. Review.

PMID:
11953684
15.

Hereditary hemochromatosis: a case study and review.

Laudicina RJ, Legrys VA.

Clin Lab Sci. 2001 Summer;14(3):196-208; quiz 220-2. Review.

PMID:
11517631
16.

A reader's guide to surgical decision analysis.

Birkmeyer JD, Welch HG.

J Am Coll Surg. 1997 Jun;184(6):589-95. Review.

PMID:
9179115
17.

Population screening for hemochromatosis: has the time finally come?

Barton JC, Acton RT.

Curr Gastroenterol Rep. 2000 Feb;2(1):18-26. Review.

PMID:
10980999
18.
19.

Principles of cancer screening.

MacLean CD.

Med Clin North Am. 1996 Jan;80(1):1-14. Review.

PMID:
8569290
20.

Understanding screening: requirements for a successful programme.

Davis JP, Crombie IK, Davies HT.

Hosp Med. 2001 Feb;62(2):104-7. Review.

PMID:
11236609

Supplemental Content

Support Center